2007
DOI: 10.2146/ajhp060428
|View full text |Cite
|
Sign up to set email alerts
|

Varenicline: The newest agent for smoking cessation

Abstract: Varenicline, a newly approved agent for smoking cessation, offers a new option to patients who cannot tolerate the adverse effects associated with nicotine-replacement therapy and bupropion. It is also an alternative to consider in patients with contraindications to such therapies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
23
0
3

Year Published

2008
2008
2014
2014

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 38 publications
(26 citation statements)
references
References 9 publications
0
23
0
3
Order By: Relevance
“…While prolonged stimulation by most entities usually causes receptor downregulation, nicotine stimulation at the acetylcholine receptors causes upregulation. This upregulation desensitizes acetylcholine receptors, which results in nicotine dependence and addiction [Potts and Garwood, 2007].…”
Section: Me (A) (B)mentioning
confidence: 99%
See 1 more Smart Citation
“…While prolonged stimulation by most entities usually causes receptor downregulation, nicotine stimulation at the acetylcholine receptors causes upregulation. This upregulation desensitizes acetylcholine receptors, which results in nicotine dependence and addiction [Potts and Garwood, 2007].…”
Section: Me (A) (B)mentioning
confidence: 99%
“…In vivo studies found that the dopamine response to varenicline is 3260% of the response of nicotine. Varenicline competitively inhibits nicotine, thereby blocking the effects of nicotine at the a4b2 receptor site and so alleviate the nicotine withdrawal symptoms [Potts and Garwood, 2007]. …”
Section: Bupropionmentioning
confidence: 99%
“…Im Durchschnitt erhalten nur 38% der Raucher ärzt-liche Unterstützungsangebote (Spannweite 0-100%; [12]). Nikotinersatztherapie [33], Bupropion [21] und Vareniclin können den Anteil erfolgreicher Raucherentwöhnungen signifikant steigern, wie zahlreiche kontrollierte Studien belegen [30,31], weitere Substanzen wie Rimonabant und Nikotinimpfungen sind derzeit in Entwicklung [16].…”
Section: > Ex-raucher Leben Länger Als Aktive Raucher Und Sind Bei Beunclassified
“…Cytisine, derived from the plant Cytisus laburnum, has been used in Eastern Europe to aid in smoking cessation for over forty years and is currently being sold under the brand name Tabex ® . 2,3 Varenicline has been modified to have greater bioavailability and selectivity for the α 4 β 2 receptor subtype, but to a lower level than nicotine. The highest concentration of α 4 β 2 nicotinic receptors can be found on the dopamine and γ-aminobutyric acid-containing neurons, and with its agonist activity varenicline both blocks the nicotine receptor as well as stimulates dopamine release.…”
mentioning
confidence: 99%
“…The highest concentration of α 4 β 2 nicotinic receptors can be found on the dopamine and γ-aminobutyric acid-containing neurons, and with its agonist activity varenicline both blocks the nicotine receptor as well as stimulates dopamine release. 2,4 The effects of this receptor activation are thought to be of importance in dependence, thereby reducing the craving for nicotine. 4 Currently, there are no published reports of varenicline overdose.…”
mentioning
confidence: 99%